KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
Aims to build the largest connected healthcare ecosystem in India
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country
Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Subscribe To Our Newsletter & Stay Updated
